Literature DB >> 29957064

Additive Effects of Intermittent Hypobaric Hypoxia and Endurance Training on Bodyweight, Food Intake, and Oxygen Consumption in Rats.

Ignacio Cabrera-Aguilera1, David Rizo-Roca1,2, Elisa A Marques3, Garoa Santocildes1, Teresa Pagès1, Gines Viscor1, António A Ascensão2, José Magalhães2, Joan Ramon Torrella1.   

Abstract

Cabrera-Aguilera, Ignacio, David Rizo-Roca, Elisa A. Marques, Garoa Santocildes, Teresa Pagès, Gines Viscor, António A. Ascensão, José Magalhães, and Joan Ramon Torrella. Additive effects of intermittent hypobaric hypoxia and endurance training on bodyweight, food intake, and oxygen consumption in rats. High Alt Med Biol. 19:278-285, 2018.-We used an animal model to elucidate the effects of an intermittent hypobaric hypoxia (IHH) and endurance exercise training (EET) protocol on bodyweight (BW), food and water intake, and oxygen consumption. Twenty-eight young adult male rats were divided into four groups: normoxic sedentary (NS), normoxic exercised (NE), hypoxic sedentary (HS), and hypoxic exercised (HE). Normoxic groups were maintained at an atmospheric pressure equivalent to sea level, whereas the IHH protocol consisted of 5 hours per day for 33 days at a simulated altitude of 6000 m. Exercised groups ran in normobaric conditions on a treadmill for 1 hour/day for 5 weeks at a speed of 25 m/min. At the end of the protocol, both hypoxic groups showed significant decreases in BW from the ninth day of exposure, reaching final 10% (HS) to 14.5% (HE) differences when compared with NS. NE rats also showed a significant weight reduction after the 19th day, with a decrease of 7.4%. The BW of hypoxic animals was related to significant hypophagia elicited by IHH exposure (from 8% to 12%). In contrast, EET had no effect on food ingestion. Total water intake was not affected by hypoxia but was significantly increased by exercise. An analysis of oxygen consumption at rest (mL O2/[kg·min]) revealed two findings: a significant decrease in both hypoxic groups after the protocol (HS, 21.7 ± 0.70 vs. 19.1 ± 0.78 and HE, 22.8 ± 0.80 vs. 17.1 ± 0.90) and a significant difference at the end of the protocol between NE (21.3 ± 0.77) and HE (17.1 ± 0.90). These results demonstrate that IHH and EET had an additive effect on BW loss, providing evidence that rats underwent a metabolic adaptation through a reduction in oxygen consumption measured under normoxic conditions. These data suggest that the combination of IHH and EET could serve as an alternative treatment for the management of overweight and obesity.

Entities:  

Keywords:  endurance exercise training; intermittent hypobaric hypoxia; oxygen consumption; weight loss

Mesh:

Year:  2018        PMID: 29957064     DOI: 10.1089/ham.2018.0013

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  4 in total

1.  Effects of Living High-Training Low and High on Body Composition and Metabolic Risk Markers in Overweight and Obese Females.

Authors:  Huan Gao; Jianfang Xu; Li Zhang; Yingli Lu; Binghong Gao; Lianshi Feng
Journal:  Biomed Res Int       Date:  2020-02-11       Impact factor: 3.411

2.  Redox status biomarkers in the fast-twitch extensor digitorum longus resulting from the hypoxic exercise.

Authors:  Eda Ağaşcıoğlu; Rıdvan Çolak; Ufuk Çakatay
Journal:  Nagoya J Med Sci       Date:  2022-05       Impact factor: 0.794

Review 3.  Physiological and Biological Responses to Short-Term Intermittent Hypobaric Hypoxia Exposure: From Sports and Mountain Medicine to New Biomedical Applications.

Authors:  Ginés Viscor; Joan R Torrella; Luisa Corral; Antoni Ricart; Casimiro Javierre; Teresa Pages; Josep L Ventura
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

4.  Alterations in the innate immune system due to exhausting exercise in intensively trained rats.

Authors:  Sheila Estruel-Amades; Mariona Camps-Bossacoma; Malén Massot-Cladera; Francisco J Pérez-Cano; Margarida Castell
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.